Notice Information
Notice Title
Rituximab 100mg & 500mg vials
Notice Description
Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland.
Lot Information
Lot 1
Supply of Rituximab 100mg & 500mg vials to health boards across NHS Scotland. Both product lines were grouped together and awarded as an unranked multi supplier framework agreement.. Access to contract pricing is to be given to the designated Compounding company for supply to Participating Authorities across NHS Scotland.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000489840
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN287738
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £15,300,000 £10M-£100M
- Lots Value
- £15,300,000 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 27 Jun 20178 years ago
- Submission Deadline
- 8 May 2017Expired
- Future Notice Date
- Not specified
- Award Date
- 2 Jun 20178 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LARKHALL
- Postcode
- ML9 2QX
- Post Town
- Motherwell
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR279402
Rituximab 100mg & 500mg vials - Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN287738
Rituximab 100mg & 500mg vials - Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000489840-2017-06-27T00:00:00Z",
"date": "2017-06-27T00:00:00Z",
"ocid": "ocds-r6ebe6-0000489840",
"initiationType": "tender",
"parties": [
{
"id": "org-1",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Canderside Toll, 2 Swinhill Avenue",
"locality": "Larkhall",
"region": "UKM",
"postalCode": "ML9 2QX"
},
"contactPoint": {
"name": "Bronwyn Bainbridge",
"email": "bronwyn.bainbridge@nhs.net",
"telephone": "+44 1698794410",
"url": "http://www.publictendersscotland.publiccontractsscotland.gov.uk"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-4",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Stuart Gillespie",
"email": "stuart.gillespie@nhs.net",
"telephone": "+44 1698794585",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"id": "org-4"
},
"tender": {
"id": "NP46717",
"title": "Rituximab 100mg & 500mg vials",
"description": "Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
}
],
"value": {
"amount": 15300000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"tenderPeriod": {
"endDate": "2017-05-08T12:00:00Z"
},
"awardPeriod": {
"startDate": "2017-05-08T12:00:00Z"
},
"documents": [
{
"id": "APR279402",
"documentType": "contractNotice",
"title": "Rituximab 100mg & 500mg vials",
"description": "Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR279402",
"format": "text/html"
},
{
"id": "JUN287738",
"documentType": "awardNotice",
"title": "Rituximab 100mg & 500mg vials",
"description": "Supply of Rituximab 100mg & 500mg vials to Health Boards across NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN287738",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "Supply of Rituximab 100mg & 500mg vials to health boards across NHS Scotland. Both product lines were grouped together and awarded as an unranked multi supplier framework agreement.. Access to contract pricing is to be given to the designated Compounding company for supply to Participating Authorities across NHS Scotland.",
"status": "complete",
"value": {
"amount": 15300000,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
}
}
],
"bidOpening": {
"date": "2017-05-08T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes."
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"maximumParticipants": 3
}
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false
},
"language": "EN",
"description": "The estimated values referred to in Sections II.I.7 and V.2.4 cover the initial twenty-four (24) month duration and the twelve (12) month extension period of the framework agreement. (SC Ref:501257)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000489840"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000489840"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP46717",
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "NP46717",
"awardID": "NP46717",
"status": "active",
"dateSigned": "2017-06-02T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2017/S 069-130029"
}
]
}